WS Data Solutions
Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Neutral
Debt to Equity Rating
Strong Buy
Price to Earnings Rating
Sell
Analyst Rating
Buy
Simple Moving Average
Sell
Exponential Moving Average
Sell
Relative Strength Index
Buy
Standard Deviation
Strong Buy
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Sell
Wall Street Data Solutions Rating
Buy
A
Royalty Pharma plc Class A Ordinary Shares (RPRX)
Pharmaceutical Preparations
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
110 EAST 59TH STREET
NEW YORK, NY
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
06/16/2020
Market Cap
12,306,434,200
Shares Outstanding
446,690,000
Weighted SO
446,688,809
Total Employees
N/A
Upcoming Earnings
08/08/2024
Beta
0.4580
Last Div
0.8400
Range
25.2-31.655
Chg
0.0200
Avg Vol
2812591
Mkt Cap
12306434200
Exch
NASDAQ
Country
US
Phone
212 883 0200
DCF Diff
-56.5085
DCF
84.8135
Div Yield
0.0378
P/S
5.4999
EV Multiple
18.5746
P/FV
1.8957
Div Yield %
3.7840
P/E
18.2355
PEG
2.6222
Payout
0.5464
Current Ratio
9.3548
Quick Ratio
9.3548
Cash Ratio
6.4006
DSO
126.2057
DIO
0.0000
Op Cycle
126.2057
DPO
9.0611
CCC
117.1446
Gross Margin
0.5784
Op Margin
0.4292
Pretax Margin
0.4604
Net Margin
0.3009
Eff Tax Rate
0.3458
ROA
0.0381
ROE
0.1050
ROCE
0.0553
NI/EBT
0.6535
EBT/EBIT
1.0728
EBIT/Rev
0.4292
Debt Ratio
0.4305
D/E
1.1738
LT Debt/Cap
0.5400
Total Debt/Cap
0.5400
Int Coverage
5.1552
CF/Debt
0.3529
Equity Multi
2.7264
Rec Turnover
2.8921
Pay Turnover
40.2823
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.1267
OCF/Share
5.9478
FCF/Share
0.8791
Cash/Share
3.9979
OCF/Sales
1.1989
FCF/OCF
0.1478
CF Coverage
0.3529
ST Coverage
0.0000
CapEx Coverage
1.1734
Div&CapEx Cov
1.0108
P/BV
1.8957
P/B
1.8957
P/S
5.4999
P/E
18.2355
P/FCF
31.0395
P/OCF
4.5765
P/CF
4.5765
PEG
2.6222
P/S
5.4999
EV Multiple
18.5746
P/FV
1.8957
DPS
1.0300
Latest Headlines (EST)
Revenue Product Segmentation
Dividend History
| Cash Value | Ex-Dividend Date | Declaration Date | Record Date | Pay Date |
|---|---|---|---|---|
| 0.21 | 08/16/2024 | 07/17/2024 | 08/16/2024 | 09/13/2024 |
| 0.21 | 05/16/2024 | 04/17/2024 | 05/17/2024 | 06/14/2024 |
| 0.21 | 02/15/2024 | 01/19/2024 | 02/16/2024 | 03/15/2024 |
| 0.20 | 11/16/2023 | 10/16/2023 | 11/17/2023 | 12/15/2023 |
| 0.20 | 08/17/2023 | 07/17/2023 | 08/18/2023 | 09/15/2023 |
| 0.20 | 05/18/2023 | 04/17/2023 | 05/19/2023 | 06/15/2023 |
| 0.20 | 02/15/2023 | 01/09/2023 | 02/16/2023 | 03/15/2023 |
| 0.19 | 11/17/2022 | 10/17/2022 | 11/18/2022 | 12/15/2022 |
| 0.19 | 08/18/2022 | 07/15/2022 | 08/19/2022 | 09/15/2022 |
| 0.19 | 05/19/2022 | 04/18/2022 | 05/20/2022 | 06/15/2022 |
| 0.19 | 02/17/2022 | 01/06/2022 | 02/18/2022 | 03/15/2022 |
| 0.17 | 11/18/2021 | 10/15/2021 | 11/19/2021 | 12/15/2021 |
| 0.17 | 08/19/2021 | 07/16/2021 | 08/20/2021 | 09/15/2021 |
| 0.17 | 05/19/2021 | 04/15/2021 | 05/20/2021 | 06/15/2021 |
| 0.17 | 02/18/2021 | 01/08/2021 | 02/19/2021 | 03/15/2021 |
| 0.15 | 11/19/2020 | 10/15/2020 | 11/20/2020 | 12/15/2020 |
| 0.15 | 09/14/2020 | 09/02/2020 | 09/15/2020 | 09/30/2020 |